Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-004628-14Phase 3Terminated
Phase 3, randomised trial of fentanyl, levobupivacaine and bupivacaine in colon cancer, colorectal neoplasm, diverticulitis and 1 more (2 arms), sponsored by Oulu University Hospital. Primary endpoint: Post-operative hospital stay length. Started Oct 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-004628-14.